Search Results 9401-9410 of 33161 for oral
requiring home oxygen, chronic nebulizer therapy, chronic oral steroid therapy or hospitalized for pulmonary decompensation within 12 months of informed ...
... Oral and throat cancer, Adenocarcinoma, Laryngeal cancer, Carotid body tumor, Tongue base cancer, Mouth tumor, Salivary gland cancer, Parotid cancer ...
Prior Oral Contraceptive Use Associated with Better Outcome for Ovarian Cancer Patients. Joe Dangor. November 11, 2015. Cardiovascular. Genetic Risk Information ...
Patients on oral anticholinesterase, anti-seizure medications, and magnesium sulfate. Participating Mayo Clinic locations. Study statuses change often ...
... oral board examinees in different practice settings. Int Urogynecol J. 2019 Jul; 30 (7):1153-1161 Epub 2018 Apr 13. View PubMed; Hassani DB, Mangel JM ...
Is unable to take oral medications, or has malabsorption syndrome or any other uncontrolled gastrointestinal condition (e.g., nausea, diarrhea or vomiting) ...
Are unable to take oral medication OR have malabsorption syndrome or any other uncontrolled gastrointestinal condition (eg, nausea, diarrhea, vomiting) that ...
Injectable single hormone, oral hormonal contraceptive (e.g., combined or progesterone only), contraceptive medication patch, or estrogen/progestin vaginal ...
Christopher F. Viozzi, M.D., D.D.S.. Oral and Maxillofacial Surgeon. Rochester, MN ...
Cancer. Prior Oral Contraceptive Use Associated with Better Outcome for Ovarian Cancer Patients. Joe Dangor. November 11, 2015. Cardiovascular. Genetic Risk ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.